
A Fortune 500 life sciences organisation required a scalable way to extract structured information from informed consent forms (ICFs). These documents determine whether patient biological samples can legally be used for internal research.
The client engaged Hybrid Mind for their AI specialism to build the extraction pipeline, accelerate delivery, and guide AI adoption within a multidisciplinary team including tech leads, data engineers, AI testers, product owners, and program managers.
The client engaged Hybrid Mind for their AI specialism to build the extraction pipeline, accelerate delivery, and guide AI adoption within a multidisciplinary team including tech leads, data engineers, AI testers, product The program faced several major challenges:
ICFs contain exception-heavy rules that historically lived only in the heads of domain experts. This knowledge needed to be formalised and embedded into an AIsystem.
The work required development of an internal platform unfamiliar to most engineers.
Compliance constraints prevented direct model access and required complex procedures for experimentation.
After an abrupt departure of the previous AI engineer, our specialist was required to make architectural decisions quickly to meet release deadlines.
Provides rapid architectural decisions and guidance on AI testing strategy during a critical delivery period.
Quantifiable Benefit:
This work establishes the foundation for a compliant enterprise consent intelligence system, unlocking more value from internal biological samples.
It demonstrates Hybrid Mind’s strengths in:
